longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Yatsen

YSG

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -8.04, within the reasonable range, cheaper than 66.69% of the time in the past 5 years, and the industry ranks 37/54, the industry Median -0.30.

-8.04xP/E
$2.58Stock price
$-0.32Earnings per share
-8.04xP/E
Stock price$2.58Earnings per share$-0.32

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-5.04x
Typical range
-11.43x–-3.03x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
04998147196

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
SSDOYUSShiseido
-68.75x--$9.01B
COTYUSCoty
-3.88x115.33%$2.40B
EPCUSEdgewell Personal Care
-13.21x85.53%$1.23B
GLASUSGlass House Brands
-11.91x--$763.36M
HNSTUSHonest
-48.95x166.37%$595.43M
USNAUSUSANA Health Sciences
-12.73x205.17%$282.14M
YSGUSYatsen
-8.04x34.23%$242.01M
NUSUSNu Skin
-1.10x248.43%$237.06M
WALDUSWaldencast
-0.66x65.17%$151.35M
MEDUSMedifast
-5.24x44.71%$134.17M
SKINUSSkinHealth
-3.20x8.39%$91.11M
UPXIUSUpexi
-0.34x--$76.74M
BHSTUSBioHarvest Sciences
-3.68x12.08%$40.80M
DSYUSBig Tree Cloud
----$17.25M
ZIVOUSZivo Bioscience
-2.01x--$17.02M
MTEXUSMannatech
-2.08x--$15.44M
NHTCUSNatural Health Trend
-8.56x--$13.90M
HYEXUSHealthy Extracts Inc.
-15.10x--$13.27M
NAIIUSNatural Alternatives
-0.86x--$12.30M
CABRUSCaring Brands
-1.22x--$12.03M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.